Evernorth, which provides pharmacy care and benefits solutions, announced layoffs back in April impacting 62 employees at its ...

Bloomfield, Connecticut-based The Cigna Group (CI) provides insurance and related products and services. Valued at a market ...

Cigna trades at a significant discount to the S&P 500, offering a higher yield and faster dividend growth, making it ...

In a rebrand of its health services portfolio, Cigna is launching Evernorth, which includes pharmacy benefit manager Express Scripts, specialty pharmacy Accredo and eviCore healthcare, which provides ...

Cigna will also relaunch existing solutions such as Embarc Benefit Protection—which ensures members who need them have access to high-cost gene therapies—under the Evernorth branding.

Cigna’s $2.5 billion bid to beef up Evernorth’s value-based offerings comes following concerns from market watchers that the payer could be falling behind in the frenzy of insurer M&A.

Cigna’s Evernorth Health Services is launching an outpatient behavioral health practice as health insurers integrate mental health services with medical care to better address patient needs.

The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

Cigna's Evernorth unit said in an announcement that pharmacies participating in EnReachRx will offer both 30-day and 90-day prescriptions for GLP-1s based on the patient's coverage. Patients will ...

Cigna's Evernorth has gone national in its partnership with mental wellness provider Meru Health. Addressing burnout is one of the Meru app's targets and a rarely discussed aspect of healthcare's ...

Cigna’s Evernorth healthcare services business will buy MDLive, a fast-growing provider of telehealth services that have taken off during the Covid-19 pandemic. Newsletters Games Share a News Tip.

Cigna's health services division Evernorth has entered into a definitive agreement to acquire fast-growing telehealth vendor MDLive, banking on continued demand for virtual care post-COVID-19.